Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia

BACKGROUND: Reduction in elevated serum cholesterol concentrations is important in the management of individuals at risk of atherosclerotic cardiovascular disease (ASCVD), such as myocardial infarction and thrombotic stroke. Although HMGCoA reductase inhibitors (“statins”) are frequently used for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bisceglie, Adrian M., Watts, Gerald F., Lavin, Philip, Yu, Meng, Bai, Ru, Liu, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661247/
https://www.ncbi.nlm.nih.gov/pubmed/33183320
http://dx.doi.org/10.1186/s12944-020-01406-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661247/
https://www.ncbi.nlm.nih.gov/pubmed/33183320
http://dx.doi.org/10.1186/s12944-020-01406-4

Ejemplares similares